FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q3 2023

Top Holdings164 positions

Checking export access…
Activity:
SPYSPY
PUT

State Street Spdr S&p 500 Etf Trust TR UNIT

8.7M$3.7B17.4%———
Increased
—

ACTIVISION BLIZZARD INC

20.3M$1.9B8.9%——
7 qtrssince 2022-Q1
Increased
100
VMWVMWDelisted

VMWARE INC

5.5M$915.4M4.3%——
6 qtrssince 2022-Q2
Increased
80

HORIZON THERAPEUTICS PUB L

6.7M$770.1M3.6%——
10 qtrssince 2021-Q2
Decreased
0

UnitedHealth Group Inc.

1.3M$679M3.2%$445.17+6.36%
3 qtrssince 2023-Q1
Increased
62

TRANSUNION

9.2M$662.9M3.1%$86.03-17.55%
20 qtrssince 2018-Q4
Decreased
0

EXELIXIS INC

25.9M$565M2.6%$19.21+13.75%
20 qtrssince 2018-Q4
Unchanged
0

IQVIA Holdings Inc.

2.8M$544.3M2.5%$159.39+23.44%
20 qtrssince 2018-Q4
Decreased
0

Thermo Fisher Scientific Inc

1M$530.2M2.5%$417.19+20.16%
16 qtrssince 2019-Q4
Decreased
0

SALESFORCE COM INC

2.5M$512.1M2.4%$173.51+15.47%
16 qtrssince 2019-Q4
Increased
68

CHARTER COMMUNICATIONS INC N

1.1M$488.8M2.3%$439.820.00%
1 qtr
New
81
SGENSGENDelisted

SEAGEN INC

2.3M$481.7M2.2%——
3 qtrssince 2023-Q1
Increased
87

Alphabet Inc.

3.6M$469M2.2%$93.01+40.43%
20 qtrssince 2018-Q4
Decreased
0

Microsoft Corp.

1.3M$426M2.0%$213.45+44.54%
20 qtrssince 2018-Q4
Increased
70

ARAMARK

12.1M$421.1M2.0%$24.75-1.90%
12 qtrssince 2020-Q4
Increased
55
AZNAZN
ADR

ASTRAZENECA PLC

6.1M$410.4M1.9%$115.41+12.04%
9 qtrssince 2021-Q3
Unchanged
0

S&P Global Inc

999,395$365.2M1.7%$298.42+13.08%
6 qtrssince 2022-Q2
Decreased
0

WABTEC

3.3M$346M1.6%$73.27+42.89%
20 qtrssince 2018-Q4
Increased
49

Analog Devices Inc.

1.9M$340M1.6%$181.57-7.15%
2 qtrssince 2023-Q2
Decreased
0

CBRE GROUP INC

4.5M$333.9M1.6%$73.860.00%
1 qtr
New
71
$21.4B
AUM
164
Positions
Q3 2023
Filing
HI score · 1.5/5
Quarterly 13F Value Change
-6%Q2'22$17B-4%Q3'22$16.3B-5%Q4'22$15.5B+7%Q1'23$16.5B+1%Q2'23$16.7B+6%Q3'23$17.7B
Activity profile
$ moved · Q3'23
New17%Increased44%Decreased21%Exited18%
Composition
Equity vs derivatives
Equity83%Puts17%Calls0%
Holding period
Avg 2.1 years
<1Q15%1-4Q13%1-2Y24%2Y+48%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $21.4B across 164 positions as of Q3 2023. Top holdings: SPY puts (17.4%), ATVI (8.9%), VMW (4.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.

Q3 2023 Summary

Active quarter - 33 new positions, 41 exits, 27 increased. Top move: ATVI (INCREASED, conviction 100). Portfolio: $21.4B across 164 positions.

Top holdings by portfolio weight

Total AUM$18B
ATVI8.88%
VMW4.27%
HZNP3.59%
UNH3.17%
TRU3.09%
EXEL2.64%
IQV2.54%
TMO2.47%
CRM2.39%
CHTR2.28%
Other2.25%

Portfolio allocation by GICS sector

Sectors11
Healthcare30.94%
Unknown25.38%
Technology13.15%
Financial Services11.17%
Communication Services7.48%
Industrials5.74%
Real Estate3.62%
Basic Materials1.60%
Consumer Cyclical0.44%
Utilities0.40%
Other0.08%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L48
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBoston Scientific Corporation
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used